Keywords: سیتارابین; Cytarabine; Self-assemble; Nanoparticles; Leukemia treatment;
مقالات ISI سیتارابین (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: سیتارابین; Ara-C; cytarabine; LA; lauric acid; LA-Ara; conjugation of cytarabine with lauric acid; LA-Ara NFs; LA-Ara nanofibers; AML; acute myeloid leukaemia; ALL; acute lymphoblastic leukaemia; lg P; oil/water partition coefficient; Ara-CTP; cytarbine triphosphate
Keywords: سیتارابین; Cladribine; Cytarabine; Idarubicin; Acute myeloid leukemia; Induction chemotherapy; Leukemia risk; NCCN; ELN; Anthracycline; Risk prediction; Prognosis; AML;
Keywords: سیتارابین; MDR; multi-drug resistance; PPI; polypropyleneimine; RBC; red blood cell; WBC; white blood cell; LDH; lactate dehydrogenase; EPR; enhances permeability and retention; FA; folic acid; FR; FA receptor; SMUT; sodium-dependent multi-vitamin transporter; FITC;
Keywords: سیتارابین; Autologous stem cell transplant; Cytarabine; High dose; Mantle cell lymphoma; Rituximab;
Keywords: سیتارابین; Cytarabine; Solubility; Solvent; Thermodynamic analysis;
Synthesis of dual-action parthenolide prodrugs as potent anticancer agents
Keywords: سیتارابین; Parthenolide; Cytarabine; Melphalan; aza-Michael addition; Cytotoxic activity;
Keywords: سیتارابین; PCNSL; Radiotherapy; Cerebrospinal fluid; Methotrexate; Cytarabine; Thiotepa; Rituximab;
Keywords: سیتارابین; AML; acute myeloid leukemia; ANG-1; angiopoietin-1; ALL; acute lymphoblastic leukemia; AKT; protein kinase B; Ara-C; cytarabine; AXL; tyrosine kinase receptor; BCL-2; B-cell lymphoma 2; BH3; BCL-2 homology 3; BMP; bone morphogenic protein; CAR cell; CXCL1
Keywords: سیتارابین; Cytarabine; Human serum albumin; Interaction; Fluorescence quenching; Molecular docking;
Keywords: سیتارابین; Antineoplastic; Cytarabine; Photodegradation; UV radiation; Radical promoter
Keywords: سیتارابین; Transdermal delivery; Deformable liposomes; Cytarabine; Leukemia; Factorial design; Transfersomes;
Keywords: سیتارابین; Cytostatic agents; Emerging contaminants; Environmental samples; Liquid chromatography; Gas chromatography; 5-FU; 5-Fluorouracil; ACT-D; actinomycin-D; A-GLU; Aminoglutethimide; APCI; atmospheric pressure chemical ionization; APPI; atmospheric pressure ph
Keywords: سیتارابین; Acute myeloid leukemia; Myelodysplastic syndromes; Clofarabine; Cytarabine;
Keywords: سیتارابین; cytarabine; dermatopathology; drug reactions; pathophysiology; toxic erythema of chemotherapy
Keywords: سیتارابین; acute myeloid leukemia; adjunct; AML; anthracycline; chemotherapy; consolidation; cytarabine; induction; non-transplant; targeted agents
Keywords: سیتارابین; Glucose-functionalized; Terpolymer; Cytarabine; Fluorodeoxyuridine; Cytotoxicity;
Keywords: سیتارابین; Acute myeloid leukemia; Clinical trial; Cytarabine; Lenalidomide; Phase I; Relapse/refractory AML
Report of the relapsed/refractory cohort of SWOG S0919: A phase 2 study of idarubicin and cytarabine in combination with pravastatin for acute myelogenous leukemia (AML)
Keywords: سیتارابین; Acute myeloid leukemia; Relapsed; Refractory; Pravastatin; Idarubicin; Cytarabine;
Increased activity of both CDK1 and CDK2 is necessary for the combinatorial activity of WEE1 inhibition and cytarabine
Keywords: سیتارابین; WEE1; AZD1775; Cytarabine; Leukemia; CDK1; CDK2; DNA damage; Apoptosis;
Efficacy of Standard Dose R-CHOP Alternating With R-HDAC Followed by Autologous Hematopoietic Cell Transplantation as Initial Therapy of Mantle Cell Lymphoma, a Single-Institution Experience
Keywords: سیتارابین; Autologous hematopoietic cell transplantation; Cytarabine; Mantle cell lymphoma; Nordic regimen; Outcome;
Langerhans cell histiocytosis in children
Keywords: سیتارابین; BRAF; cladribine; clofarabine; cytarabine; diabetes insipidus; Langerhans cell histiocytosis; steroids; vinblastine;
What is the optimal initial management of the older MCL patient?
Keywords: سیتارابین; Mantle cell lymphoma; Elderly patients; Induction therapy; Maintenance therapy; R-CHOP; Bendamustine; Cytarabine; Lenalidomide; Bortezomib; Toxicity;
Involvement of nucleoside transporters in the transcorneal permeation of topically instilled substrates in rabbits in-vivo
Keywords: سیتارابین; Ocular; Nucleoside transporters; Transcorneal; ent; cnt; Ribavirin; Cytarabine;
Do cytogenetics affect the post-remission strategy for older patients with AML in CR1?
Keywords: سیتارابین; Acute myeloid leukemia; Age; AML; Azacitidine; Clofarabine; Consolidation; CPX-351; Cytarabine; Cytogenetics; Daunorubicin; Decitabine; Minimal residual disease; MRD; Reduced intensity conditioning; RIC; Risk; TP53; Transplant;
Chidamide in FLT3-ITD positive acute myeloid leukemia and the synergistic effect in combination with cytarabine
Keywords: سیتارابین; Chidamide; FLT3-ITD; Cytarabine; Acute myeloid leukemia;
Synergistic Cytotoxicity of Lenalidomide and Dexamethasone in Mantle Cell Lymphoma via Cereblon-dependent Targeting of the IL-6/STAT3/PI3K Axis
Keywords: سیتارابین; MCL; mantle cell lymphoma; CRBN; cereblon; Lenalidomide; Lena; Dexamethasone; Dex; LD; lenalidomide and dexamethasone; OS; overall survival; Ara-C; cytarabine; MTX; methotrexate; DDP; cisplatin; CTX; cyclophosphamide; THP; therarubicin; Lenalidomide; Dexa
Research paperRandomized phase II trial of cytosine arabinoside with and without the CHK1 inhibitor MK-8776 in relapsed and refractory acute myeloid leukemia
Keywords: سیتارابین; Leukemia; AML; Chk1; Cytarabine; MK-8776;
BRAF signals to pro-apoptotic BIM to enhance AraC cytotoxicity induced in AML cells by Vitamin D-based differentiation agents
Keywords: سیتارابین; Vitamin D; BRAF; BIM; Apoptosis; Cytarabine; AML;
Monophosphorylation by deoxycytidine kinase affects apparent cellular uptake of decitabine in HCT116 colon cancer cells
Keywords: سیتارابین; Equilibrative nucleoside transporter 1; Uridine; Decitabine; Deoxycytidine kinase; Monophosphorylation; Irinotecan; Etoposide; Cytarabine; Gemcitabine; Kinetics;
CPX-351 exhibits potent and direct ex vivo cytotoxicity against AML blasts with enhanced efficacy for cells harboring the FLT3-ITD mutation
Keywords: سیتارابین; CPX-351; Cytarabine; Daunorubicin; Leukemia; Cytotoxicity;
Nanoassemblies from amphiphilic cytarabine prodrug for leukemia targeted therapy
Keywords: سیتارابین; Cytarabine; Amphiphilic small molecular prodrug; Nanoassembly; Folic acid; Leukemia therapy;
How can one optimize induction therapy in AML?
Keywords: سیتارابین; Acute myeloid leukemia; AML; Ara-C; Azacitidine; Induction; Cladribine; Clofarabine; CPX-351; Cytarabine; Daunorubicin; Etoposide; Fludarabine; Gemtuzumab ozogamicin; Idarubicin; Vadastuximab talirine;
Cytarabine degradation by simulated solar assisted photocatalysis using TiO2
Keywords: سیتارابین; Antineoplastic drugs; AOPs; Cytarabine; TiO2; Toxicity; Transformation products;
Simultaneous determination of clofarabine and cytarabine in human plasma by LC-MS/MS
Keywords: سیتارابین; AML; acute myeloid leukemia; ALL; acute lymphoid leukemia; CFB; clofarabine; CLARA; chemotherapy regimen with clofarabine 40Â mg/m2 and cytarabine 1000Â mg/m2; CTB; cytarabine; ESI; electrospray ionisation; HSCT; hematopoietic stem cell transplantation; I
HPLC-MS/MS method for the simultaneous determination of MB07133 and its metabolites, cytarabine and arabinofuranosyluracil, in rat plasma
Keywords: سیتارابین; Prodrug; MB07133; Cytarabine; Arabinofuranosyluracil; HPLC-MS/MS
The novel HSP90 inhibitor NVP-AUY922 shows synergistic anti-leukemic activity with cytarabine in vivo
Keywords: سیتارابین; Tyrosine kinase; HSP90; NVP-AUY922; Cytarabine; KG-1a leukemia;
Idarubicin-intensified BUCY2 conditioning regimen improved survival in high-risk acute myeloid, but not lymphocytic leukemia patients undergoing allogeneic hematopoietic stem cell transplantation: A retrospective comparative study
Keywords: سیتارابین; allo-HSCT; allogeneic hematopoietic stem cell transplantation; IDA; idarubicin; AML; acute myeloid leukemia; ALL; acute lymphocytic leukemia; OS; overall survival; DFS; disease-free survival; RR; relapse rate; BU; busulfan; CY; cyclophosphamide; VP-16; et
The hematopoietic tumor suppressor interferon regulatory factor 8 (IRF8) is upregulated by the antimetabolite cytarabine in leukemic cells involving the zinc finger protein ZNF224, acting as a cofactor of the Wilms’ tumor gene 1 (WT1) protein
Keywords: سیتارابین; Leukemia; IRF8; WT1; ZNF224; Cytarabine; Transcription
Genipin-modified gelatin nanocarriers as swelling controlled drug delivery system for in vitro release of cytarabine
Keywords: سیتارابین; Gelatin; Nanocarriers; Cytarabine; Drug release;
Sugar-modified poly(propylene imine) dendrimers as drug delivery agents for cytarabine to overcome drug resistance
Keywords: سیتارابین; ALL; acute lymphocytic leukemia; AML; acute myeloid leukemia; Ara-C; cytarabine; Ara-CTP; cytarabine triphosphate; CDD; cytidine deaminase; dCK; deoxycytidine kinase; DP; dipyridamole; FBS; fetal bovine serum; hENT1; human equilibrative nucleoside transpo
Transporter-targeted cholic acid-cytarabine conjugates for improved oral absorption
Keywords: سیتارابین; Cytarabine; Bile acid transporters; Prodrugs; Oral bioavailability;
Improving antiproliferative effect of the anticancer drug cytarabine on human promyelocytic leukemia cells by coating on Fe3O4@SiO2 nanoparticles
Keywords: سیتارابین; Magnetic nanoparticles; Coprecipitation reaction; Cytarabine; Antiproliferative effect; Human promyelocytic leukemia cell line;
Regioselective synthesis of 5â²-amino acid esters of some nucleosides via orthogonal protecting protocol
Keywords: سیتارابین; Regioselective synthesis; Orthogonal protection; Cytarabine; Gemcitabine; Oligopeptide transporters;
Synthesis and antileukemic activities of C1-C10-modified parthenolide analogues
Keywords: سیتارابین; PTL; parthenolide; LSC; leukemic stem cell; AML; acute myeloid leukemia; SL; sesquiterpene lactone; HSC; hematopoietic stem cell; DMAPT; dimethylamino-parthenolide; MelB; melampomagnolide B; ROS; reactive oxygen species; PtO2; platinum(IV) oxide; DME; dim
Alterations of DNA repair genes in the NCI-60 cell lines and their predictive value for anticancer drug activity
Keywords: سیتارابین; DNA repair; Cancer; SLX4/FANCP/BTBD12; Cytarabine; Raltitrexed; NCI-60
Obatoclax potentiates the cytotoxic effect of cytarabine on acute myeloid leukemia cells by enhancing DNA damage
Keywords: سیتارابین; Acute myeloid leukemia; Obatoclax; Cytarabine; DNA damage; Drug combination;
A Post Hoc Sensitivity Analysis of Survival Probabilities in a Multinational Phase III Trial of Decitabine in Older Patients With Newly Diagnosed Acute Myeloid Leukemia
Keywords: سیتارابین; Age factors; Chemotherapy; Cytarabine; Dacogen; Treatment outcome;
Optimal dose and schedule of consolidation in AML: Is there a standard?
Keywords: سیتارابین; acute myeloid leukemia; AML; cytarabine; ara-C; high-dose; intermediate-dose
Management of persistent AML at day 14
Keywords: سیتارابین; acute myeloid leukemia; allogeneic hematopoietic cell transplantation; ara-C; AML; cytarabine; daunorubicin; day 14; HCT; HiDAC; high-dose ara-C; idarubicin; multiparameter flow cytometry; MPFC; persistence